Peritumoral and Periganglionic Infiltration of Levobupivacaine Prior to Conservative Surgery for Triple-negative Breast Cancer
NCT07458204
·
clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
760
Enrollment
OTHER
Sponsor class
Conditions
Triple-negative Breast Cancer
Interventions
DRUG:
LVB infiltration
Sponsor
Institut Jean-Godinot